Effects of Prebiotic Therapy on Gastrointestinal Microbiome of Individuals with Different Inflammatory Conditions: A Systematic Review of Randomized Controlled Trials-Reference-Cited by-同舟云学术

Effects of Prebiotic Therapy on Gastrointestinal Microbiome of Individuals with Different Inflammatory Conditions: A Systematic Review of Randomized Controlled Trials

Published:2023-04-24 Issue: Volume: Page:
ISSN:1867-1306
Container-title:Probiotics and Antimicrobial Proteins
language:en
Short-container-title:Probiotics & Antimicro. Prot.

Author:

Ribeiro M. C.,Levi YLAS,Moraschini V.,Messora M. R.,Furlaneto F. A. C.

Publisher

Springer Science and Business Media LLC

Subject

Molecular Biology,Molecular Medicine,Microbiology

Link

https://link.springer.com/content/pdf/10.1007/s12602-023-10075-5.pdf

Reference88 articles.

1. Gibson GR et al (2017) Expert consensus document: the International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroentero Hepatol 14(8). Nature Publishing Group, pp. 491–502, Aug. 01, 2017. https://doi.org/10.1038/nrgastro.2017.75.

2. Cunningham M et al (2021) Shaping the future of probiotics and prebiotics. Trends Microbiol 29(8). Elsevier Ltd, pp. 667–685, Aug. 01, 2021. https://doi.org/10.1016/j.tim.2021.01.003.

3. Xie W et al (2013) miR-181a regulates inflammation responses in monocytes and macrophages. PLoS One 8(3):e58639. Mar. 2013. https://doi.org/10.1371/journal.pone.0058639.

4. Ferrero-Miliani L, Nielsen OH, Andersen PS, Girardin SE (2007) Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1β generation. Clin Exp Immunol 147(2):227–235. https://doi.org/10.1111/j.1365-2249.2006.03261.x

5. Forbes JD et al (2018) A comparative study of the gut microbiota in immune-mediated inflammatory diseases - does a common dysbiosis exist?. Microbiome 6(1). Dec. 2018. https://doi.org/10.1186/s40168-018-0603-4.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Usefulness of Resistant Maltodextrin and Chitosan Oligosaccharide in Management of Gut Leakage and Microbiota in Chronic Kidney Disease;Nutrients;2023-07-28